title: Medical Abortion.
abstract: OBJECTIVE
  This guideline reviews the evidence relating to the provision of first-trimester medical induced abortion, including patient eligibility, counselling, and consent; evidence-based regimens; and special considerations for clinicians providing medical abortion care.
  Gynaecologists, family physicians, registered nurses, midwives, residents, and other healthcare providers who currently or intend to provide pregnancy options counselling, medical abortion care, or family planning services.
  
  
  METHODS
  Women with an unintended first trimester pregnancy.
  
  
  METHODS
  Published literature was retrieved through searches of PubMed, MEDLINE, and Cochrane Library between July 2015 and November 2015 using appropriately controlled vocabulary (MeSH search terms: Induced Abortion, Medical Abortion, Mifepristone, Misoprostol, Methotrexate). Results were restricted to systematic reviews, randomized controlled trials, clinical trials, and observational studies published from June 1986 to November 2015 in English. Additionally, existing guidelines from other countries were consulted for review. A grey literature search was not required.
  
  
  METHODS
  The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force for Preventive Medicine rating scale (Table 1).
  
  
  RESULTS
  Medical abortion is safe and effective. Complications from medical abortion are rare. Access and costs will be dependent on provincial and territorial funding for combination mifepristone/misoprostol and provider availability.
  
  
  CONCLUSIONS
  Introduction Pre-procedure care Medical abortion regimens Providing medical abortion Post-abortion care
  
  
  CONCLUSIONS
  Introduction Pre-procedure care Medical abortion regimens Providing medical abortion Post-abortion care.
authors.affiliation: Hamilton ON.
authors.forename: Dustin
authors.initials: D
authors.lastname: Costescu
authors.affiliation: Quebec QC.
authors.forename: Edith
authors.initials: E
authors.lastname: Guilbert
authors.affiliation: Moncton NB.
authors.forename: Jeanne
authors.initials: J
authors.lastname: Bernardin
authors.affiliation: Ottawa ON.
authors.forename: Amanda
authors.initials: A
authors.lastname: Black
authors.affiliation: Toronto ON.
authors.forename: Sheila
authors.initials: S
authors.lastname: Dunn
authors.affiliation: Vancouver BC.
authors.forename: Brian
authors.initials: B
authors.lastname: Fitzsimmons
authors.affiliation: Vancouver BC.
authors.forename: Wendy V
authors.initials: WV
authors.lastname: Norman
authors.affiliation: Winnipeg MB.
authors.forename: Helen
authors.initials: H
authors.lastname: Pymar
authors.affiliation: Vancouver BC.
authors.forename: Judith
authors.initials: J
authors.lastname: Soon
authors.affiliation: Victoria BC.
authors.forename: Konia
authors.initials: K
authors.lastname: Trouton
authors.affiliation: Montréal QC.
authors.forename: Marie-Soleil
authors.initials: MS
authors.lastname: Wagner
authors.affiliation: Vancouver BC.
authors.forename: Ellen
authors.initials: E
authors.lastname: Wiebe
authors.affiliation: Toronto ON.
authors.forename: Karen
authors.initials: K
authors.lastname: Gold
authors.affiliation: Montréal QC.
authors.forename: Marie-Ève
authors.initials: MÈ
authors.lastname: Murray
authors.affiliation: New York, NY, USA.
authors.forename: Beverly
authors.initials: B
authors.lastname: Winikoff
authors.affiliation: Washington, DC, USA.
authors.forename: Matthew
authors.initials: M
authors.lastname: Reeves
mesh_terms: D000019:Abortifacient Agents; D000028:Abortion, Induced; D002170:Canada; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D049168:Pregnancy, Unplanned
chemical_list: D000019:Abortifacient Agents
keywords: early abortion; induced abortion; medical abortion; mifepristone; misoprostol